IP Library › Granted Patent US 10,150,795
Granted Patent B2
US 10,150,795 · App. 15/512,193 · Granted Dec 11, 2018

Peptide having antimicrobial activity against pathogens and antimicrobial peptide composition comprising the same

Inventors: Yong Ae Kim (Gyeonggi-do, KR); Ji Sun Kim (Seoul, KR); Ji Ho Jeong (Gyeonggi-do, KR)
Assignee: HANKUK UNIVERSITY OF FOREIGN STUDIES RESEARCH & BUSINESS FOUNDATION
C07K7/08A61P31/04C07K4/12C07K7/06C07K14/47A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,150,795
App. No.
15/512,193
Granted
Dec 11, 2018
Kind
B2
Abstract

An antimicrobial peptide and an antimicrobial peptide composition comprising the same are provided. The antimicrobial peptide and the antimicrobial peptide composition have remarkably high antibacterial activity against gram-positive (+) and gram-negative (−) bacteria, compared to wild-type LPcin-I having an antimicrobial ability, which consists of a sequence of 23 amino acids. Also, the antimicrobial peptide can be useful in being easily synthesized and saving production costs since the antimicrobial peptide has a smaller number of amino acids, compared to the wild-type LPcin-I.

Claims (22)

1. A peptide represented by the following sequence [General Formula I] having antimicrobial activity against pathogens:

[General Formula I]

[(N-terminus)-N K V K E W X 1  K X 2  L K X 3  X 4  F 

X 5 -(C-terminus)]

wherein X 1 is I or W, X 2 is Y when X 1 is I, and X 2 is W when X 1 is W;

X 3 is S or K;

X 4 is L or K; and

X 5 is S or K,

wherein the sequence of the peptide is not NKVKEWIKYLKSLFS (SEQ ID NO: 1).

2. The peptide of claim 1 , wherein the peptide is a peptide from which X 3 X 4 F X 5 or F X 5 in General Formula I is deleted.

3. The peptide of claim 1 , wherein the peptide consists of any one amino acid sequence selected from the group consisting of SEQ ID NOs: 2 to 10.

4. An antimicrobial peptide composition comprising the antimicrobial peptide of any one of claims 1 to 3 as an active ingredient.

5. The antimicrobial peptide composition of claim 4 , wherein the antimicrobial activity is antimicrobial activity against one or more bacteria selected from the group consisting of Staphylococcus aureus, Salmonella spp., Listeria innocua, Pseudomonas aeruginosa , and Escherichia coli.

6. A peptide represented by the following sequence [General Formula I] having antimicrobial activity against pathogens:

[General Formula I]

[(N-terminus)-

N K V K E W X 1  K X 2  L K X 3  X 4  F X 5 -(C-terminus)]

wherein X 1 is I or W, X 2 is Y when X 1 is I, and X 2 is W when X 1 is W;

X 3 is S or K;

X 4 is L or K; and

X 5 is S or K, and

wherein the peptide is a peptide from which X 3 X 4 F X 5 or F X 5 in General Formula I is deleted.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2017
From: KIM, YONG AE; KIM, JI SUN; JEONG, JI HO
To: HANKUK UNIVERSITY OF FOREIGN STUDIES RESEARCH & BUSINESS FOUNDATION
Reel/Frame 041622/0297 →
Priority Claims (1)
KR 10-2016-0051073 · Apr 26, 2016 · national
Continuity (1)
Related Publication 20180170965A1 · Jun 21, 2018
Cited By (1)
US 12,319,752